home.aspx
 
. https://biotechnology.report/Resources/Whitepapers/c982b041-7610-4adb-b210-e4a99e81df3d_Targeted Therapies Drives Small Manufacturing[1].pdf
whitepaper
SHARESHARESHARE
RISE IN TARGETED THERAPIES DRIVES NEEDS FOR SMALL VOLUME MANUFACTURING
Biologics have experienced steady double-digit growth over the last 15 years and now comprise slightly more than a quarter of all New Molecular Entity (NME) FDA approvals. Similarly, EvaluatePharma's 2017 report on orphan drugs projects that by 2020, six of the 10 best-selling global drug therapies will be biologic sterile injectable drugs. DOWNLOAD